The molecular basis of the host response to lipopolysaccharide
The DOI matches its Crossref record; 67 of the 67 references it cites were found in a registry or an index.
Abstract
Lipopolysaccharide (LPS), which is produced by Gram-negative bacteria, is a powerful activator of innate immune responses. LPS binds to the proteins Toll-like receptor 4 (TLR4) and MD2 to activate pro-inflammatory signalling pathways. The TLR4-MD2 receptor complex is crucial for the host recognition of Gram-negative bacterial infection, and pathogens have devised many strategies to evade or manipulate TLR4-MD2 activity. The TLR4-MD2 signalling pathway is therefore potentially an important therapeutic target. This Progress article focuses on recent exciting data that have revealed the structural basis of TLR4-MD2 recognition of LPS.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Given that the acylation state of LPS lipid A has been shown to directly impact immune signalling through TLR46,21”
From Gut microbiota-derived hexa-acylated lipopolysaccharides enhance cancer immunotherapy responses (2025) · cites this paper as [21]
In the citing paper
“Endotoxin causes inflammatory activation mainly via activating TLR4 (with co-receptor MD2) on the cell surface, resulting in NF-κB transcriptional activation of hundreds of inflammatory genes, including pro-inflammatory cytokines such as TNFα, IL-6 and pro-IL-1β [4, 17, 18].”
From The endotoxin hypothesis of neurodegeneration (2019) · cites this paper as [18]
In the citing paper
“High doses of endotoxin in blood (endotoxemia) cause a ‘cytokine storm’, septic shock and death, via activating TLR4, RAGE and caspases [16, 18, 20, 21].”
From The endotoxin hypothesis of neurodegeneration (2019) · cites this paper as [18]
In the citing paper
“we now know that (i) endotoxin is released by bacteria and (ii) the toxicity of endotoxin is due to the host’s inflammatory over-reaction to it, rather than an intrinsic toxicity to animal cells [3, 16, 18].”
From The endotoxin hypothesis of neurodegeneration (2019) · cites this paper as [18]
Citations
Cites
Pathogen Recognition and Innate Immunity
Akira, S., Uematsu, S., & Takeuchi, O. (2006) · Cell · doi:10.1016/j.cell.2006.02.015 · Cited by 11,952 · cited 1×
“The role of TLR4 in LPS signalling was confirmed in Tlr4 −/− mice, which were shown to be hyporesponsive to LP”
BackgroundDefective LPS Signaling in C3H/HeJ and C57BL/10ScCr Mice: Mutations in Tlr4 Gene
Poltorak, A., He, X., Smirnova, I., Liu, M.-Y., Huffel, C. V., Du, X., Birdwell, D., Alejos, E., Silva, M., Galanos, C., et al. (1998) · Science · doi:10.1126/science.282.5396.2085 · Cited by 7,631
A human homologue of the Drosophila Toll protein signals activation of adaptive immunity
Medzhitov, R., Preston-Hurlburt, P., & Janeway, C. A. (1997) · Nature · doi:10.1038/41131 · Cited by 5,590
Raetz, C. R. H., & Whitfield, C. (2002) · Annual Review of Biochemistry · doi:10.1146/annurev.biochem.71.110601.135414 · Cited by 4,404
CD14, a Receptor for Complexes of Lipopolysaccharide (LPS) and LPS Binding Protein
Wright, S. D., Ramos, R. A., Tobias, P. S., Ulevitch, R. J., & Mathison, J. C. (1990) · Science · doi:10.1126/science.1698311 · Cited by 3,987
Approaching the Asymptote? Evolution and Revolution in Immunology
Janeway, C. A. (1989) · Cold Spring Harbor Symposia on Quantitative Biology · doi:10.1101/sqb.1989.054.01.003 · Cited by 3,252 · cited 1×
“Detecting lipopolysaccharide It is 20 years since Janeway proposed the existence of pattern recognition receptors (PRRs”
BackgroundThe family of five: TIR-domain-containing adaptors in Toll-like receptor signalling
O'Neill, L. A. J., & Bowie, A. G. (2007) · Nature Reviews Immunology · doi:10.1038/nri2079 · Cited by 2,667 · cited 1×
“There are five adaptor proteins that function in TLR signalling, and they all contain TIR domain”
BackgroundThe structural basis of lipopolysaccharide recognition by the TLR4–MD-2 complex
Park, B. S., Song, D. H., Kim, H. M., Choi, B.-S., Lee, H., & Lee, J.-O. (2009) · Nature · doi:10.1038/nature07830 · Cited by 2,428
MD-2, a Molecule that Confers Lipopolysaccharide Responsiveness on Toll-like Receptor 4
Shimazu, R., Akashi, S., Ogata, H., Nagai, Y., Fukudome, K., Miyake, K., & Kimoto, M. (1999) · The Journal of Experimental Medicine · doi:10.1084/jem.189.11.1777 · Cited by 2,185 · cited 1×
“Further genetic and biochemical studies revealed that expression of TLR4 alone does not confer LPS responsiveness, and that an additional co-receptor protein, MD2 (also known as LY96), is require”
BackgroundTLR4 mutations are associated with endotoxin hyporesponsiveness in humans
Arbour, N. C., Lorenz, E., Schutte, B. C., Zabner, J., Kline, J. N., Jones, M., Frees, K., Watt, J. L., & Schwartz, D. A. (2000) · Nature Genetics · doi:10.1038/76048 · Cited by 2,024
Structure and Function of Lipopolysaccharide Binding Protein
Schumann, R. R., Leong, S. R., Flaggs, G. W., Gray, P. W., Wright, S. D., Mathison, J. C., Tobias, P. S., & Ulevitch, R. J. (1990) · Science · doi:10.1126/science.2402637 · Cited by 1,672 · cited 1×
“LPS from infecting bacteria is extracted and solubilized by a serum protein, LPS-binding protein ( LBP”
MethodEndotoxin-tolerant Mice Have Mutations in Toll-like Receptor 4 (Tlr4)
Qureshi, S. T., Larivière, L., Leveque, G., Clermont, S., Moore, K. J., Gros, P., & Malo, D. (1999) · The Journal of Experimental Medicine · doi:10.1084/jem.189.4.615 · Cited by 1,525
Crystal Structure of the TLR1-TLR2 Heterodimer Induced by Binding of a Tri-Acylated Lipopeptide
Jin, M. S., Kim, S. E., Heo, J. Y., Lee, M. E., Kim, H. M., Paik, S.-G., Lee, H., & Lee, J.-O. (2007) · Cell · doi:10.1016/j.cell.2007.09.008 · Cited by 1,344
The Extra Domain A of Fibronectin Activates Toll-like Receptor 4
Okamura, Y., Watari, M., Jerud, E. S., Young, D. W., Ishizaka, S. T., Rose, J., Chow, J. C., & Strauss, J. F. (2001) · Journal of Biological Chemistry · doi:10.1074/jbc.m100099200 · Cited by 1,216 · cited 1×
“and the type III repeat extra domain of fibronecti”
BackgroundCrystal Structure of the TLR4-MD-2 Complex with Bound Endotoxin Antagonist Eritoran
Kim, H. M., Park, B. S., Kim, J.-I., Kim, S. E., Lee, J., Oh, S. C., Enkhbayar, P., Matsushima, N., Lee, H., Yoo, O. J., et al. (2007) · Cell · doi:10.1016/j.cell.2007.08.002 · Cited by 1,177
Hammad, H., Chieppa, M., Perros, F., Willart, M. A., Germain, R. N., & Lambrecht, B. N. (2009) · Nature Medicine · doi:10.1038/nm.1946 · Cited by 1,139 · cited 1×
“A mouse model challenge with Der p 2 led to experimental allergic asthma in wild-type and MD2-deficient, but not TLR4-deficient, animal”
MethodEssential role of MD-2 in LPS responsiveness and TLR4 distribution
Nagai, Y., Akashi, S., Nagafuku, M., Ogata, M., Iwakura, Y., Akira, S., Kitamura, T., Kosugi, A., Kimoto, M., & Miyake, K. (2002) · Nature Immunology · doi:10.1038/ni809 · Cited by 1,020
LPS, TLR4 and infectious disease diversity
Miller, S. I., Ernst, R. K., & Bader, M. W. (2005) · Nature Reviews Microbiology · doi:10.1038/nrmicro1068 · Cited by 998
The Vaccine Adjuvant Monophosphoryl Lipid A as a TRIF-Biased Agonist of TLR4
Mata-Haro, V., Cekic, C., Martin, M., Chilton, P. M., Casella, C. R., & Mitchell, T. C. (2007) · Science · doi:10.1126/science.1138963 · Cited by 896
Phosphoinositide-Mediated Adaptor Recruitment Controls Toll-like Receptor Signaling
Kagan, J. C., & Medzhitov, R. (2006) · Cell · doi:10.1016/j.cell.2006.03.047 · Cited by 847 · cited 1×
“MAL also contains a phosphatidylinositol-4,5-bisphosphate-binding domain that localizes it to the plasma membran”
BackgroundAllergenicity resulting from functional mimicry of a Toll-like receptor complex protein
Trompette, A., Divanovic, S., Visintin, A., Blanchard, C., Hegde, R. S., Madan, R., Thorne, P. S., Wills-Karp, M., Gioannini, T. L., Weiss, J. P., et al. (2009) · Nature · doi:10.1038/nature07548 · Cited by 762 · cited 1×
“all require MD2 for activation of TLR4, but Der p 2 (Ref”
BackgroundHaziot, A., Ferrero, E., Köntgen, F., Hijiya, N., Yamamoto, S., Silver, J., Stewart, C. L., & Goyert, S. M. (1996) · Immunity · doi:10.1016/s1074-7613(00)80254-x · Cited by 743
Structural Basis of Toll-Like Receptor 3 Signaling with Double-Stranded RNA
Liu, L., Botos, I., Wang, Y., Leonard, J. N., Shiloach, J., Segal, D. M., & Davies, D. R. (2008) · Science · doi:10.1126/science.1155406 · Cited by 733 · cited 1×
“This arrangement of the two TLR4–MD2 heterodimers brings the C-terminal, juxtamembrane sequences of the ectodomains into close proximity and has a similar 'M'-shaped conformation to that of TLR1 and TLR2 complexed by tri-acylated lipid and that of the TLR3 ectodomain bound to double-stranded RN”
BackgroundRelevance of Mutations in the TLR4 Receptor in Patients With Gram-Negative Septic Shock
Lorenz, E., Mira, J. P., Frees, K. L., & Schwartz, D. A. (2002) · Archives of Internal Medicine · doi:10.1001/archinte.162.9.1028 · Cited by 729
Structure and Function of Toll Receptors and Their Ligands
Gay, N. J., & Gangloff, M. (2007) · Annual Review of Biochemistry · doi:10.1146/annurev.biochem.76.060305.151318 · Cited by 667
Self-citationNeubig, R. R., Spedding, M., Kenakin, T., & Christopoulos, A. (2003) · Pharmacological Reviews · doi:10.1124/pr.55.4.4 · Cited by 665
Structures of the Toll-like Receptor Family and Its Ligand Complexes
Jin, M. S., & Lee, J.-O. (2008) · Immunity · doi:10.1016/j.immuni.2008.07.007 · Cited by 558 · cited 1×
“The diglucosamine backbones are fully exposed to solven”
BackgroundMansell, A., Smith, R., Doyle, S. L., Gray, P., Fenner, J. E., Crack, P. J., Nicholson, S. E., Hilton, D. J., O'Neill, L. A. J., & Hertzog, P. J. (2006) · Nature Immunology · doi:10.1038/ni1299 · Cited by 514 · cited 1×
“MAL is phosphorylated by Bruton tyrosine kinase ( BTK ); phosphorylation is required for MAL to signal and subsequently leads to its degradatio”
BackgroundDarveau, R. P., Pham, T.-T. T., Lemley, K., Reife, R. A., Bainbridge, B. W., Coats, S. R., Howald, W. N., Way, S. S., & Hajjar, A. M. (2004) · Infection and Immunity · doi:10.1128/iai.72.9.5041-5051.2004 · Cited by 507 · cited 1×
“gingivalis LPS can activate two innate immune receptors simultaneousl”
BackgroundCrystal Structures of Human MD-2 and Its Complex with Antiendotoxic Lipid IVa
Ohto, U., Fukase, K., Miyake, K., & Satow, Y. (2007) · Science · doi:10.1126/science.1139111 · Cited by 471 · cited 1×
“This model was confirmed by structural analyses of MD2 bound to lipid IVa and of a TLR4–MD2 heterodimer in complex with the antagonist eritora”
MethodLipid A-like molecules that antagonize the effects of endotoxins on human monocytes.
Golenbock, D. T., Hampton, R. Y., Qureshi, N., Takayama, K., & Raetz, C. R. (1991) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)55023-7 · Cited by 416
Virulence factors of Yersinia pestis are overcome by a strong lipopolysaccharide response
Montminy, S. W., Khan, N., McGrath, S., Walkowicz, M. J., Sharp, F., Conlon, J. E., Fukase, K., Kusumoto, S., Sweet, C., Miyake, K., et al. (2006) · Nature Immunology · doi:10.1038/ni1386 · Cited by 408 · cited 1×
“pestis can produce a mixture of stimulatory and non-stimulatory LPS specie”
BackgroundCirl, C., Wieser, A., Yadav, M., Duerr, S., Schubert, S., Fischer, H., Stappert, D., Wantia, N., Rodriguez, N., Wagner, H., et al. (2008) · Nature Medicine · doi:10.1038/nm1734 · Cited by 393
Gioannini, T. L., Teghanemt, A., Zhang, D., Coussens, N. P., Dockstader, W., Ramaswamy, S., & Weiss, J. P. (2004) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0306906101 · Cited by 366 · cited 1×
“The main role for CD14 is to enhance the sensitivity of myeloid cells to LPS, reducing the binding affinity to picomolar concentration”
BackgroundGenetic control of susceptibility to Salmonella typhimurium in mice: role of the LPS gene.
O'Brien, A. D., Rosenstreich, D. L., Scher, I., Campbell, G. H., MacDermott, R. P., & Formal, S. B. (1980) · The Journal of Immunology · doi:10.4049/jimmunol.124.1.20 · Cited by 354
E5531, a Pure Endotoxin Antagonist of High Potency
Christ, W. J., Asano, O., Robidoux, A. L. C., Perez, M., Wang, Y., Dubuc, G. R., Gavin, W. E., Hawkins, L. D., McGuinness, P. D., Mullarkey, M. A., et al. (1995) · Science · doi:10.1126/science.7701344 · Cited by 318
TAK-242 selectively suppresses Toll-like receptor 4-signaling mediated by the intracellular domain
Kawamoto, T., Ii, M., Kitazaki, T., Iizawa, Y., & Kimura, H. (2008) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2008.01.026 · Cited by 313 · cited 1×
“Many antagonists of TLR4–MD2 have been identified already, some of which are based on the lipid A structures and other small-molecule inhibitor”
BackgroundMullarkey, M., Rose, J. R., Bristol, J., Kawata, T., Kimura, A., Kobayashi, S., Przetak, M., Chow, J., Gusovsky, F., Christ, W. J., et al. (2003) · The Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.102.044487 · Cited by 292
Rowe, D. C., McGettrick, A. F., Latz, E., Monks, B. G., Gay, N. J., Yamamoto, M., Akira, S., O’Neill, L. A., Fitzgerald, K. A., & Golenbock, D. T. (2006) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0510041103 · Cited by 286 · cited 1×
“Similarly, TRAM is myristoylated at its N terminus, which localizes it to the plasma membran”
BackgroundSelf-citationProtection from lethal Gram-negative bacterial sepsis by targeting Toll-like receptor 4
Roger, T., Froidevaux, C., Le Roy, D., Reymond, M. K., Chanson, A.-L., Mauri, D., Burns, K., Riederer, B. M., Akira, S., & Calandra, T. (2009) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0808146106 · Cited by 269 · cited 1×
“It will be interesting to see how successful selective TLR4 antagonists, or TLR4-specific antibodie”
BackgroundRoles for LPS-dependent interaction and relocation of TLR4 and TRAM in TRIF-signaling
Tanimura, N., Saitoh, S., Matsumoto, F., Akashi-Takamura, S., & Miyake, K. (2008) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2008.01.061 · Cited by 250
ML — a conserved domain involved in innate immunity and lipid metabolism
Inohara, N., & Nuñez, G. (2002) · Trends in Biochemical Sciences · doi:10.1016/s0968-0004(02)02084-4 · Cited by 242 · cited 1×
“An important step forward in our understanding of LPS recognition by the TLR4–MD2 heterodimer came with the discovery that MD2 belongs to a small family of lipid-binding proteins, the MD2-related lipid recognition famil”
BackgroundSaitoh, S.-I. (2004) · International Immunology · doi:10.1093/intimm/dxh097 · Cited by 236
Tidswell, M., Tillis, W., LaRosa, S. P., Lynn, M., Wittek, A. E., Kao, R., Wheeler, J., Gogate, J., & Opal, S. M. (2010) · Critical Care Medicine · doi:10.1097/ccm.0b013e3181b07b78 · Cited by 229 · cited 1×
“; these trials were initially not very promising, owing to poor patient selection, but recent data suggest a trend towards reduced mortalit”
ResultRallabhandi, P., Bell, J., Boukhvalova, M. S., Medvedev, A., Lorenz, E., Arditi, M., Hemming, V. G., Blanco, J. C. G., Segal, D. M., & Vogel, S. N. (2006) · The Journal of Immunology · doi:10.4049/jimmunol.177.1.322 · Cited by 219
Inhibition of FcεRI-mediated mast cell responses by ES-62, a product of parasitic filarial nematodes
Melendez, A. J., Harnett, M. M., Pushparaj, P. N., Wong, W. F., Tay, H. K., McSharry, C. P., & Harnett, W. (2007) · Nature Medicine · doi:10.1038/nm1654 · Cited by 196
Sensing Gram-Negative Bacterial Lipopolysaccharides: a Human Disease Determinant?
Munford, R. S. (2008) · Infection and Immunity · doi:10.1128/iai.00939-07 · Cited by 189 · cited 1×
“It is unclear whether pathogens have evolved the ability to change their lipid A structure in order to evade the host, or whether this simply reflects a change in the bacterium to accommodate different environmental niche”
BackgroundNúñez Miguel, R., Wong, J., Westoll, J. F., Brooks, H. J., O'Neill, L. A. J., Gay, N. J., Bryant, C. E., & Monie, T. P. (2007) · PLoS ONE · doi:10.1371/journal.pone.0000788 · Cited by 189
Self-citationInternational Union of Pharmacology Committee on Receptor Nomenclature and Drug Classification.
Vanhoutte, P. M., Barnard, E. A., Cosmides, G. J., Humphrey, P. P., Spedding, M., & Godfraind, T. (1994) · Pharmacological Reviews · doi:10.1016/s0031-6997(25)06779-1 · Cited by 188
Toll-like receptors as molecular switches
Gay, N. J., Gangloff, M., & Weber, A. N. R. (2006) · Nature Reviews Immunology · doi:10.1038/nri1916 · Cited by 183
Self-citationNewman, R. M., Salunkhe, P., Godzik, A., & Reed, J. C. (2006) · Infection and Immunity · doi:10.1128/iai.74.1.594-601.2006 · Cited by 172
Radhakrishnan, G. K., Yu, Q., Harms, J. S., & Splitter, G. A. (2009) · Journal of Biological Chemistry · doi:10.1074/jbc.m805458200 · Cited by 158
Structure-Activity Relationship of Synthetic Toll-like Receptor 4 Agonists
Stöver, A. G., Da Silva Correia, J., Evans, J. T., Cluff, C. W., Elliott, M. W., Jeffery, E. W., Johnson, D. A., Lacy, M. J., Baldridge, J. R., Probst, P., et al. (2004) · Journal of Biological Chemistry · doi:10.1074/jbc.m310760200 · Cited by 156 · cited 1×
“The importance of the number of acyl chains for the activity of lipid A-like structures is illustrated by the properties of a library of synthetic monosaccharide lipid A mimetics (the aminoalkyl glucosaminide phosphate compounds) in which both the number and carbon length of the acyl chains are crucial to generate an…”
BackgroundMolecular Basis of Reduced Potency of Underacylated Endotoxins
Teghanemt, A., Zhang, D., Levis, E. N., Weiss, J. P., & Gioannini, T. L. (2005) · The Journal of Immunology · doi:10.4049/jimmunol.175.7.4669 · Cited by 149 · cited 1×
“The explanation for why underacylated lipid A causes less cell activation than hexa-acylated lipid A is likely to involve an alteration to the interaction between lipid A and the LPS receptor complex, such that receptor activation is reduce”
BackgroundTrif-related adapter molecule is phosphorylated by PKCε during Toll-like receptor 4 signaling
McGettrick, A. F., Brint, E. K., Palsson-McDermott, E. M., Rowe, D. C., Golenbock, D. T., Gay, N. J., Fitzgerald, K. A., & O'Neill, L. A. J. (2006) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0600462103 · Cited by 137 · cited 1×
“, and it undergoes phosphorylation by protein kinase Ce ( PKCe ), which is required for signallin”
BackgroundSelf-citationGruber, A., Manček, M., Wagner, H., Kirschning, C. J., & Jerala, R. (2004) · Journal of Biological Chemistry · doi:10.1074/jbc.m400993200 · Cited by 125 · cited 1×
“Modelling studies suggested that binding to LPS is mediated by the intercalation of the lipid A acyl chains into the hydrophobic core of the MD2 β-sandwic”
BackgroundResman, N., Vašl, J., Oblak, A., Pristovšek, P., Gioannini, T. L., Weiss, J. P., & Jerala, R. (2009) · Journal of Biological Chemistry · doi:10.1074/jbc.m901429200 · Cited by 120
MD-2: the Toll 'gatekeeper' in endotoxin signalling.
Gangloff, M., & Gay, N. (2004) · TIBS -Trends in Biochemical Sciences. Regular ed · doi:10.1016/j.tibs.2004.04.008 · Cited by 119 · cited 1×
“Modelling studies suggested that binding to LPS is mediated by the intercalation of the lipid A acyl chains into the hydrophobic core of the MD2 β-sandwic”
BackgroundSelf-citationElucidation of the MD-2/TLR4 Interface Required for Signaling by Lipid IVa
Walsh, C., Gangloff, M., Monie, T. P., Smyth, T., Wei, B., McKinley, T. J., Maskell, D. J., Gay, N. J., & Bryant, C. E. (2008) · The Journal of Immunology · doi:10.4049/jimmunol.181.2.1245 · Cited by 119
Self-citationToshchakov, V. Y., Fenton, M. J., & Vogel, S. N. (2007) · The Journal of Immunology · doi:10.4049/jimmunol.178.5.2655 · Cited by 81
Toshchakov, V. Y., & Vogel, S. N. (2007) · Expert Opinion on Biological Therapy · doi:10.1517/14712598.7.7.1035 · Cited by 47 · cited 1×
“This model predicts that MAL and TRAM bind to the same region in the TLR4 dimer interface, thus explaining why cell-permeable peptides that target the TIR BB loop outcompete both MAL-directed and TRAM-directed responses simultaneousl”
BackgroundThomas, G. L., Böhner, C. M., Williams, H. E., Walsh, C. M., Ladlow, M., Welch, M., Bryant, C. E., & Spring, D. R. (2006) · Molecular BioSystems · doi:10.1039/b517248a · Cited by 43 · cited 1×
“aeruginosa produces N -(3-oxododecanoyl)- L -homoserine lactone, which downregulates TLR4–MD2-induced signallin”
BackgroundSelf-citationFigueiredo, M. D., Moore, J. N., Vandenplas, M. L., Sun, W., & Murray, T. F. (2008) · American Journal of Veterinary Research · doi:10.2460/ajvr.69.6.796 · Cited by 36
Structure of Toll-Like Receptors
Gay, N. J., & Gangloff, M. (2007) · Handbook of experimental pharmacology · doi:10.1007/978-3-540-72167-3_9 · Cited by 32
Self-citationLipopolysaccharide from Rhodobacter sphaeroides is an agonist in equine cells
Lohmann, K. L., Vandenplas, M. L., Barton, M. H., & Moore, J. N. (2003) · Journal of Endotoxin Research · doi:10.1177/09680519030090010301 · Cited by 31 · cited 1×
“gov/sites/entrez?db=genomeprj&cmd=Retrieve&dopt=Overview&list_uids=15752"> Rhodobacter sphaeroides lipid A has five acyl chains and is an antagonist in humans and mice but an agonist in horse”
BackgroundCharacterization of a TIR-like protein from Paracoccus denitrificans
Low, L. Y., Mukasa, T., Reed, J. C., & Pascual, J. (2007) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2007.03.003 · Cited by 30
Lee, H., Brown, S. J., Rosen, H., & Tobias, P. S. (2007) · Molecular Pharmacology · doi:10.1124/mol.107.038349 · Cited by 22 · cited 1×
“Many antagonists of TLR4–MD2 have been identified already, some of which are based on the lipid A structures and other small-molecule inhibitor”
Background
Cited by
Biosynthesis and Export of Bacterial Lipopolysaccharides
Whitfield, C., & Trent, M. S. (2014) · Annual Review of Biochemistry · doi:10.1146/annurev-biochem-060713-035600 · Cited by 709
Ciprofloxacin and levofloxacin attenuate microglia inflammatory response via TLR4/NF-kB pathway
Zusso, M., Lunardi, V., Franceschini, D., Pagetta, A., Lo, R., Stifani, S., Frigo, A. C., Giusti, P., & Moro, S. (2019) · Journal of Neuroinflammation · doi:10.1186/s12974-019-1538-9 · Cited by 534
“, tumor necrosis factor (TNF)-α, interleukin (IL)-1β, and IL-6), chemokines, enzymes, and reactive oxygen and nitrogen species [11].”
BackgroundThe endotoxin hypothesis of neurodegeneration
Brown, G. C. (2019) · Journal of Neuroinflammation · doi:10.1186/s12974-019-1564-7 · Cited by 457
Gram-positive and gram-negative bacterial toxins in sepsis: A brief review
Ramachandran, G. (2014) · Virulence · doi:10.4161/viru.27024 · Cited by 411
“To trigger an innate immune response, the lipid A portion of LPS alone is sufficient, yet the adaptive immune response during infection is usually directed toward the O-antigen.(28) The key pattern recognition receptor for LPS recognition is Toll-like receptor 4 (TLR4).”
BackgroundThe role of lipopolysaccharide/toll-like receptor 4 signaling in chronic liver diseases
Soares, J.-B., Pimentel-Nunes, P., Roncon-Albuquerque, R., & Leite-Moreira, A. (2010) · Hepatology International · doi:10.1007/s12072-010-9219-x · Cited by 367
“Binding of ligands to the extracellular domains of TLRs causes a rearrangement of the receptor complex and triggers the recruitment of specific adaptor proteins to the intracellular domain, thus initiating a signaling cascade [6, 7].”
Background
Metadata
- Authors
- Bryant, C. E., Spring, D. R., Gangloff, M., & Gay, N. J.
- Affiliations
- University of Cambridge (GB)
- Corresponding author
- Bryant, Clare E.
- Venue
- Nature Reviews Microbiology
- Published
- 2009-11-30
- Volume
- 8
- Issue
- 1
- Pages
- 8-14
- ISSN
- 1740-1526 (ISSN-L)
- 1740-1534
- OpenAlex
- W1981645153
- Cited by
- 391
- References
- 67
- Citations by year
- 2026: 12 · 2025: 23 · 2024: 34 · 2023: 26 · 2022: 27 · 2021: 30 · 2020: 35 · 2019: 28 · 2018: 20 · 2017: 17 · 2016: 21 · 2015: 21 · 2014: 18 · 2013: 18 · 2012: 30
- FWCI
- 1.60
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- www.springer.com/tdm (tdm)
- Locations
- Nature Reviews Microbiology (publishedVersion)
- PubMed (publishedVersion)
- Funders
- Wellcome Trust
- Biotechnology and Biological Sciences Research Council (BB/H003916/1, BB/G002797/1, BB\C005503\1)
- Topics
- Life Sciences › Immunology and Microbiology › Immunology › Immune Response and Inflammation
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Inflammasome and immune disorders
- Life Sciences › Immunology and Microbiology › Immunology › T-cell and B-cell Immunology
- Keywords
- lipopolysaccharide, TLR4, MD-2, innate immunity, Gram-negative bacteria, host-pathogen recognition, pro-inflammatory signaling, immune evasion, therapeutic target
- MeSH terms
- Animals, Gram-Negative Bacteria, Humans, Lipopolysaccharides, Models, Molecular, Protein Binding, Molecular Structure, Signal Transduction, Cytokines, Protein Structure, Tertiary, Protein Structure, Quaternary, Toll-Like Receptor 4, Lymphocyte Antigen 96
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.